Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 903.02 12.82 (1.44%) Market Cap: 99.50 Bil Enterprise Value: 91.36 Bil PE Ratio: 25.99 PB Ratio: 3.80 GF Score: 94/100

Regeneron Pharmaceuticals Inc (REGN) Stock Estimates Data

Regeneron Pharmaceuticals Inc (REGN) 12 Month Price Targets

Regeneron Pharmaceuticals Inc (REGN) Analyst Rating